Funding for this research was provided by:
mount sinai hospital-university health network academic medical organization innovation fund
Received: 26 July 2021
Accepted: 15 December 2021
First Online: 6 January 2022
: This study was reviewed and approved by the Research Ethics Boards at University Health Network and Western University.
: Not applicable.
: GT, GB, HD, NL, BAM, DBS, SA and MK declare that they have no competing interest. DST discloses that the institution has received Mount Sinai Hospital-University Health Network Academic Medical Organization Innovation Fund, in support of this work. CM has royalty bearing license of automated planning AI technology from RaySearch Laboratories, and patent “Method And System for Automated Quality Assurance And Automated Treatment Planning in Radiation Therapy”. TP has received support from CIHR and NSERC, and has royalties from RaySearch Laboratories.